FDA Drug Application (021861) for PATANASE by ALCON PHARMS LTD

Back to FDA Applications sponsored by ALCON PHARMS LTD

Application Number021861
Product Number001
FormSPRAY, METERED;NASAL
Dosage0.665MG/SPRAY
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePATANASE
Active IngredientOLOPATADINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient OLOPATADINE HYDROCHLORIDE5


Back to FDA Applications sponsored by ALCON PHARMS LTD